Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000243863 | SCV000318995 | uncertain significance | Cardiovascular phenotype | 2013-10-15 | criteria provided, single submitter | clinical testing | The p.R17382Q variant (also known as c.52145G>A) is located in coding exon 250 of theTTNgene. This alteration results from a G to A substitution at nucleotide position 52145. The arginine at codon 17382 is replaced by glutamine, an amino acid with some similar properties. ​Based on data from the NHLBI Exome Sequencing Project (ESP), the A-allele has an overall frequency of approximately0.02% (3/12072), having been observed in0.08% (3/3812)of African American alleles, and not observed in 8260 European American alleles studied.This variant was not reported in the Database of Single Nucleotide Polymorphisms (dbSNP) or the 1000 Genomes Project. Based on protein sequence alignment, this amino acid position is highly conserved in available vertebrate species.In addition, this alteration is predicted to be probably damaging by PolyPhen in silico analysis.Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.​ |
Labcorp Genetics |
RCV000457759 | SCV000542285 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-15 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000595826 | SCV000705763 | uncertain significance | not provided | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000595826 | SCV001825206 | likely benign | not provided | 2018-08-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25417924) |
Mayo Clinic Laboratories, |
RCV000595826 | SCV005413070 | uncertain significance | not provided | 2023-07-17 | criteria provided, single submitter | clinical testing |